CANet is a Pan-Canadian multidisciplinary and multi-sectoral research and development network of investigators, well-positioned industry partners, patients, caregivers, and healthcare providers focused on arrhythmia research, technology development and commercialization, and digital transformation activities.
Millions of Canadians experience irregular heart rhythms, known as arrhythmias. Arrhythmias can cause sudden cardiac death, which kills 40,000 Canadians a year. Sudden Cardiac Death is projected to be the leading cause of morbidity and mortality in Canada by 2020.
From governance to research to disease management, patients are co-leaders across our Network.
We ensure patient partnership, involvement, and acceptability throughout the research cycle; from conception to execution, to implementation and evaluation, lead to outcomes allowing patients to co-manage their arrhythmia disorders and help produce both economic and social benefits for Canada.
To learn more about our research and CANet-funded projects, click here.
Learn more about who we are, our goals, and the impacts we’re making, click here.